Skip to main content
. 2016 Jun;28(3):330–338. doi: 10.21147/j.issn.1000-9604.2016.03.07

3.

3

Progression-free survival (PFS) of first-line trastuzumab treatment, single/sequential single agent vs. multiple agents (P=0.305).